APPIO THOMAS 4

What Happened
Thomas Appio, CEO of Bausch Health Companies Inc. (BHC), was credited with 1,137,862 performance-based restricted share units (PSUs) on February 9, 2026. The award is reported as an acquisition at $0.00 (total reported value $0) because these are equity compensation units rather than an open-market purchase. The PSUs were earned after the Board’s Talent and Compensation Committee certified achievement of the applicable financial performance metrics for the 2023–2025 performance period.

Key Details

• Transaction date: February 9, 2026; Form 4 filed February 11, 2026 (timely filing).
• Transaction type/code: Award/Grant (A).
• Shares/units credited: 1,137,862 PSUs; reported acquisition price $0.00 (no cash paid).
• Shares owned after transaction: not specified in the filing.
• Footnote: These are performance-based RSUs originally granted March 2, 2023; they were earned upon certification of performance but remain subject to a service-based vesting condition through March 2, 2026. The company will deliver the earned common shares as soon as administratively practicable after that service vesting condition is met.
• No 10b5-1 plan or tax-withholding details disclosed in this filing.

Context
PSUs are compensation awards that convert into company shares only if performance targets are met and any service/vesting conditions lapse; they are not open-market purchases or sales. Such grants reflect compensation outcomes tied to past performance periods and do not, by themselves, indicate the insider’s intent to buy or sell stock.